CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Allecra Therapeutics on the deal. Allecra Therapeutics signed an exclusive licensing agreement with Advanz Pharma Corp. Limited, a specialty pharmaceutical company with a strategic...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Merck on the deal, and Baker Mckenzie advised Chord Therapeutics SA. Merck entered into an agreement to acquire Chord Therapeutics SA, a Swiss-based...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Modag GmbH on the deal. Blomstein advised Teva Pharmaceutical Industries Limited. MODAG GmbH signed a collaboration agreement with Teva Pharmaceutical Industries Ltd. on the exclusive...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Numab Therapeutics on the deal. Numab Therapeutics closed a CHF 100 million (approximately USD 110 million) Series C financing. Numab Therapeutics is a clinical...
You must be a Standard 1 Year member to access this content.
